Clinical Report: A Bibliometric Review of B Cells and Allergic Diseases
Overview
This bibliometric review highlights the increasing scholarly engagement in the study of B cells and allergic diseases over the past two decades. Key findings include the emergence of regulatory B cells as a focus of research and the rising translational interest in B-cell-related interventions for allergic disorders.
Background
Allergic disorders represent a significant global health challenge, with rising incidence particularly among children and young adults. B lymphocytes play a crucial role in IgE-mediated immunity and tolerance, yet their full potential as modulators of allergic inflammation remains underexplored. Understanding B-cell biology is essential for developing effective therapies for allergic diseases.
Data Highlights
Data were obtained from 3,084 WoSCC publications and 71 clinical trials indexed in PubMed, showing consistent annual increases in publications and citations.
Key Findings
Annual publications and citations related to B cells and allergic diseases have risen consistently.
Research output is primarily from allergy and immunology journals, with significant contributions from Europe and the United States.
Keyword clustering indicates stable research cores around 'food allergy,' 'asthma,' and 'plasma cells.'
Emerging research areas include 'regulatory B cells' and 'innate lymphoid cells.'
Clinical trials suggest a growing interest in B-cell-related interventions for allergic disorders.
Clinical Implications
The findings underscore the importance of B cells in the pathophysiology of allergic diseases, suggesting that future therapies may benefit from targeting B-cell functions. Clinicians should be aware of the evolving landscape of B-cell research as it may inform treatment strategies and improve patient outcomes.
Conclusion
This bibliometric assessment reveals a shift in research focus towards a comprehensive understanding of B-cell biology in allergic disorders. Continued exploration in this area is essential for advancing precision medicine in allergy treatment.
